Literature DB >> 18436334

Rho GTPases in osteoclasts: orchestrators of podosome arrangement.

Stéphane Ory1, Hélène Brazier, Géraldine Pawlak, Anne Blangy.   

Abstract

Cells from the myeloid lineage, namely macrophages, dendritic cells and osteoclasts, develop podosomes instead of stress fibers and focal adhesions to adhere and migrate. Podosomes share many components with focal adhesions but differ in their molecular organization, with a dense core of polymerized actin surrounded by scaffolding proteins, kinases and integrins. Podosomes are found either isolated both in macrophages and dendritic cells or arranged into superstructures in osteoclasts. When osteoclasts resorb bone, they form an F-actin rich sealing zone, which is a dense array of connected podosomes that firmly anchors osteoclasts to bone. It delineates a compartment in which protons and proteases are secreted to dissolve and degrade the mineralized matrix. Since Rho GTPases have been shown to control F-actin stress fibers and focal adhesions in mesenchymal cells, the question of whether they could also control podosome formation and arrangement in cells from the myeloid lineage, and particularly in osteoclasts, rapidly emerged. This article considers recent advances made in our understanding of podosome arrangements in osteoclasts and how Rho GTPases may control it.

Mesh:

Substances:

Year:  2008        PMID: 18436334     DOI: 10.1016/j.ejcb.2008.03.002

Source DB:  PubMed          Journal:  Eur J Cell Biol        ISSN: 0171-9335            Impact factor:   4.492


  51 in total

1.  Osteoclastogenic activity and RANKL expression are inhibited in osteoblastic cells expressing constitutively active Gα(12) or constitutively active RhoA.

Authors:  Jun Wang; Paula H Stern
Journal:  J Cell Biochem       Date:  2010-12-15       Impact factor: 4.429

Review 2.  Signaling inputs to invadopodia and podosomes.

Authors:  Daisuke Hoshino; Kevin M Branch; Alissa M Weaver
Journal:  J Cell Sci       Date:  2013-07-10       Impact factor: 5.285

3.  Protein tyrosine phosphatase epsilon regulates integrin-mediated podosome stability in osteoclasts by activating Src.

Authors:  Shira Granot-Attas; Chen Luxenburg; Eynat Finkelshtein; Ari Elson
Journal:  Mol Biol Cell       Date:  2009-08-19       Impact factor: 4.138

4.  The Rac1 exchange factor Dock5 is essential for bone resorption by osteoclasts.

Authors:  Virginie Vives; Mélanie Laurin; Gaelle Cres; Pauline Larrousse; Zakia Morichaud; Danièle Noel; Jean-François Côté; Anne Blangy
Journal:  J Bone Miner Res       Date:  2011-05       Impact factor: 6.741

5.  3BP2 adapter protein is required for receptor activator of NFκB ligand (RANKL)-induced osteoclast differentiation of RAW264.7 cells.

Authors:  Amel GuezGuez; Virginie Prod'homme; Xavier Mouska; Alice Baudot; Claudine Blin-Wakkach; Robert Rottapel; Marcel Deckert
Journal:  J Biol Chem       Date:  2010-05-03       Impact factor: 5.157

Review 6.  Modulation of osteoclast differentiation and bone resorption by Rho GTPases.

Authors:  Heiani Touaitahuata; Anne Blangy; Virginie Vives
Journal:  Small GTPases       Date:  2014-03-10

Review 7.  Tools of the trade: podosomes as multipurpose organelles of monocytic cells.

Authors:  Stefan Linder; Christiane Wiesner
Journal:  Cell Mol Life Sci       Date:  2014-10-10       Impact factor: 9.261

8.  Breast cancer at bone metastatic sites: recent discoveries and treatment targets.

Authors:  Osama Hussein; Svetlana V Komarova
Journal:  J Cell Commun Signal       Date:  2011-01-19       Impact factor: 5.782

9.  Podosome dynamics and location in vascular smooth muscle cells require CLASP-dependent microtubule bending.

Authors:  Xiaodong Zhu; Nadia Efimova; Christopher Arnette; Steven K Hanks; Irina Kaverina
Journal:  Cytoskeleton (Hoboken)       Date:  2016-05-20

10.  β1A integrin is a master regulator of invadosome organization and function.

Authors:  Olivier Destaing; Emmanuelle Planus; Daniel Bouvard; Christiane Oddou; Cedric Badowski; Valentine Bossy; Aurelia Raducanu; Bertrand Fourcade; Corinne Albiges-Rizo; Marc R Block
Journal:  Mol Biol Cell       Date:  2010-10-06       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.